| 3BLH |
2.48 |
Crystal Structure of Human CDK9/cyclinT1 |
| 3BLQ |
2.9 |
Crystal Structure of Human CDK9/cyclinT1 in Complex with ATP |
| 3BLR |
2.8 |
Crystal Structure of Human CDK9/cyclinT1 in complex with Flavopiridol |
| 3LQ5 |
3.0 |
Structure of CDK9/CyclinT in complex with S-CR8 |
| 3MI9 |
2.1 |
Crystal structure of HIV-1 Tat complexed with human P-TEFb |
| 3MIA |
3.0 |
Crystal structure of HIV-1 Tat complexed with ATP-bound human P-TEFb |
| 3MY1 |
2.8 |
Structure of CDK9/cyclinT1 in complex with DRB |
| 3TN8 |
2.95 |
CDK9/cyclin T in complex with CAN508 |
| 3TNH |
3.202 |
CDK9/cyclin T in complex with CAN508 |
| 3TNI |
3.234 |
structure of CDK9/cyclin T F241L |
| 4BCF |
3.011 |
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
| 4BCG |
3.085 |
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
| 4BCH |
2.958 |
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
| 4BCI |
3.1 |
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
| 4BCJ |
3.162 |
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
| 4EC8 |
3.6 |
Structure of full length CDK9 in complex with cyclinT and DRB |
| 4EC9 |
3.21 |
Crystal structure of full-length cdk9 in complex with cyclin t |
| 4IMY |
2.94 |
The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat |
| 4OGR |
3.0 |
crystal structure of P-TEFb complex with AFF4 and Tat |
| 4OR5 |
2.9 |
Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4 |
| 5L1Z |
5.9 |
TAR complex with HIV-1 Tat-AFF4-P-TEFb |
| 6CYT |
3.5 |
HIV-1 TAR loop in complex with Tat:AFF4:P-TEFb |
| 6GZH |
3.17 |
Crystal Structure of Human CDK9/cyclinT1 with A86 |
| 6W9E |
3.1 |
Crystal Structure of Human CDK9/cyclinT1 in complex with MC180295 |
| 6Z45 |
3.37 |
CDK9-Cyclin-T1 complex bound by compound 24 |
| 7NWK |
2.81 |
Crystal structure of CDK9-Cyclin T1 bound by compound 6 |
